BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Arvinas to Report Third Quarter 2026 Financial Results on November 3, 2026

  October 27, 2026

   · 

  1 min read
• Press Releases

  Satellos Establishes Scientific Advisory Board to Explore the Biology of Regeneration in Aging and Neuroscience

  October 27, 2026

   · 

  7 min read
• Press Releases

  Tonix Pharmaceuticals Presented an Analysis of Phase 3 Data Demonstrating TONMYA® Improved Physical Symptoms and Functional Ability of Patients with Fibromyalgia at the IASP 2026 World Congress on Pain

  October 27, 2026

   · 

  13 min read
• Press Releases

  NeurAxis to Host Third Quarter 2026 Results and Business Update Call on Monday, November 9, 2026

  October 27, 2026

   · 

  1 min read
• Press Releases

  Repligen Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

  October 27, 2026

   · 

  22 min read
• Press Releases

  Revolune and Concept Life Sciences Partner to Help Customers Transition Multiplex IF Assays to Flexible New Workflows

  October 27, 2026

   · 

  4 min read
• Press Releases

  New Indication Application for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Accepted for Review by NMPA

  October 27, 2026

   · 

  7 min read
• Press Releases

  Notre Dame researchers develop low-cost approach to preventing catheter infections

  October 27, 2026

   · 

  2 min read
• Press Releases

  CREATE Medicines to Host Pre-Congress Workshop and Present on In Vivo CAR-T for Autoimmune Disease at APLAR 2026

  October 27, 2026

   · 

  5 min read
• Press Releases

  Vanda Pharmaceuticals Announces Positive Results from Study 3601 of NEREUS™ (tradipitant) for Prevention of GLP-1-Induced Vomiting

  October 27, 2026

   · 

  9 min read